Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul A. Brooke currently holds 221,911 shares of VIROPHARMA INC (VPHM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul A. Brooke has been a net seller of VPHM stock. They have purchased $1.9M and sold $5.3M worth of shares.
Paul A. Brooke's most recent insider trade was on Mar 31, 2020, when they sold 327 shares at $73.23 per share.
Paul A. Brooke serves as Executive at VIROPHARMA INC (VPHM). They have executed 79 insider transactions totaling $7.2M over their tenure at the company.
Paul A. Brooke holds the position of Executive at VIROPHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Paul A. Brooke has shown a selling trading pattern, with $1.9M in total purchases and $5.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul A. Brooke was on Jan 24, 2014, when they sold $6.4M worth of VPHM shares. This transaction involved 128,314 shares at $50.00 per share.
Paul A. Brooke currently owns 221,911 shares of VIROPHARMA INC (VPHM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul A. Brooke's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul A. Brooke has 79 Form 4 filings on record as an insider at VIROPHARMA INC.
Set alerts for Paul A. Brooke and 40,000+ other insiders.